Characterisation of the Novel Apoptotic and Therapeutic Activities of the Histone Deacetylase Inhibitor Romidepsin

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2256
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Histone Deacetylase Inhibitor Romidepsin Induces as a Cascade of Differential Gene Expression and Altered Histone H3K9 Marks in Myeloid Leukaemia Cells

Oncotarget
Oncology
2019English

Effect of Histone Deacetylase Inhibitor Romidepsin on the in Vitro Growth of Foetal Fibroblast Cells and Early Development of Porcine-Cloned Embryos

Italian Journal of Animal Science
2017English

The Effects of the Histone Deacetylase Inhibitor Romidepsin (FK228) Are Enhanced by Aspirin (ASA) in COX-1 Positive Ovarian Cancer Cells Through Augmentation of P21

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Histone Deacetylase Inhibitor Downregulation of BCL-Xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2001English

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

Journal of Biomedicine and Biotechnology
2011English

P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis

2019English

Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas

Laryngoscope
Otorhinolaryngology
2011English

Ischemic Preconditioning, Retinal Neuroprotection and Histone Deacetylase Activities

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2016English

Romidepsin Enhances the Efficacy of Cytarabine in Vivo, Revealing Histone Deacetylase Inhibition as a Promising Therapeutic Strategy for KMT2A-rearranged Infant Acute Lymphoblastic Leukemia

Haematologica
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy